2020 annual financial data
Pliant Therapeutics, Inc. 2020 Operating margin
Pliant Therapeutics, Inc. 2020 operating margin with verified reported values.
Direct answer
Operating margin was -99.59%.
Operating income was -41,645,000 USD and net income was -39,745,000 USD.
Operating cash flow was -37,271,000 USD.
Get free Pliant Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 41,817,000 USD
- Operating income
- -41,645,000 USD
- Net income
- -39,745,000 USD
- Operating cash flow
- -37,271,000 USD